Low glycemic index diet reduces body fat and attenuates inflammatory and metabolic responses in patients with type 2 diabetes
AUTOR(ES)
Gomes, Júnia Maria Geraldo, Fabrini, Sabrina Pinheiro, Alfenas, Rita de Cássia Gonçalves
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
05/09/2016
RESUMO
ABSTRACT Objective The aim of this study was to verify the effects of glycemic index (GI) on body composition, and on inflammatory and metabolic markers concentrations in patients with type 2 diabetes. Subjects and methods In this randomized controlled parallel trial, twenty subjects (aged 42.4 ± 5.1 years, BMI 29.2 ± 4.8 kg.m-2) were allocated to low GI (LGI) (n = 10) or high GI (HGI) (n = 10) groups. Body composition, inflammatory and metabolic markers were assessed at baseline and after 30 days of intervention. Food intake was monitored during the study using three-day food records completed on two non-consecutive weekdays and on a weekend day. Results Body fat reduced after the LGI intervention compared with baseline (P = 0.043) and with the HGI group (P = 0.036). Serum fructosamine concentration (P = 0.031) and TNF-α mRNA expression (P = 0.05) increased in the HGI group. Serum non-esterified fatty acids were greater in the HGI than in the LGI group (P = 0.032). IL-6 mRNA expression tended to decrease after the consumption of the LGI diet compared to baseline (P = 0.06). Conclusion The LGI diet reduced body fat and prevented the negative metabolic and inflammatory responses induced by the HGI diet.
Documentos Relacionados
- Number of teeth lost on diet quality and glycemic control in patients with type 2 diabetes mellitus
- Comparative Study of the Effects of a 1-Year Dietary Intervention of a Low-Carbohydrate Diet Versus a Low-Fat Diet on Weight and Glycemic Control in Type 2 Diabetes
- Applicability of the body adiposity index to estimate body fat in adolescents with type-1 diabetes mellitus
- Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes
- Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes